BIOMAT Database Logo BIOMAT Database Logo

The mannose 6-phosphate/insulin-like growth factor 2 receptor mediates plasminogen-induced efferocytosis. 2019

Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
Molecular Immunology Unit, Institute for Hygiene and Applied Immunology, Centre for Pathophysiology, Infectiology & Immunology, Medical University of Vienna, Vienna, Austria.

The plasminogen system is harnessed in a wide variety of physiological processes, such as fibrinolysis, cell migration, or efferocytosis; and accordingly, it is essential upon inflammation, tissue remodeling, wound healing, and for homeostatic maintenance in general. Previously, we identified a plasminogen receptor in the mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R, CD222). Here, we demonstrate by means of genetic knockdown, knockout, and rescue approaches combined with functional studies that M6P/IGF2R is up-regulated on the surface of macrophages, recognizes plasminogen exposed on the surface of apoptotic cells, and mediates plasminogen-induced efferocytosis. The level of uptake of plasminogen-coated apoptotic cells inversely correlates with the TNF-α production by phagocytes indicating tissue clearance without inflammation by this mechanism. Our results reveal an up-to-now undetermined function of M6P/IGF2R in clearance of apoptotic cells, which is crucial for tissue homeostasis.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074084 THP-1 Cells A human leukemia monocytic cell line derived from a patient with LEUKEMIA, MONOCYTIC, ACUTE. It is used as a model to study the function of MONOCYTES and MACROPHAGES, their signaling pathways, nutrient and drug transport. THP-1 Cell Line,Cell Line, THP-1,Cell Lines, THP-1,Cell, THP-1,Cells, THP-1,THP 1 Cell Line,THP 1 Cells,THP-1 Cell,THP-1 Cell Lines
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D017527 Receptor, IGF Type 2 A receptor that is specific for IGF-II and mannose-6-phosphate. The receptor is a 250-kDa single chain polypeptide which is unrelated in structure to the type 1 IGF receptor (RECEPTOR, IGF TYPE 1) and does not have a tyrosine kinase domain. IGF Type 2 Receptor,IGF-II Receptor,Receptor, IGF-II,Receptor, Insulin-Like Growth Factor II,Receptor, Insulin-Like Growth Factor Type 2,Receptor, Mannose-6-Phosphate,IGF-2 Receptor,Insulin-Like-Growth-Factor II Receptor,Mannose-6-Phosphate Receptor,Receptors, IGF-2,Receptors, Insulin-Like Growth Factor II,IGF 2 Receptor,IGF II Receptor,IGF-2 Receptors,Insulin Like Growth Factor II Receptor,Mannose 6 Phosphate Receptor,Receptor, IGF II,Receptor, IGF-2,Receptor, Insulin Like Growth Factor II,Receptor, Insulin Like Growth Factor Type 2,Receptor, Insulin-Like-Growth-Factor II,Receptor, Mannose 6 Phosphate,Receptors, IGF 2,Receptors, Insulin Like Growth Factor II

Related Publications

Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
Insulin-like growth factor-2/mannose-6 phosphate receptors.
January 2009, Vitamins and hormones,
Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids.
August 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
Mannose 6-phosphate/insulin-like growth factor II receptor: distinct binding sites for mannose 6-phosphate and insulin-like growth factor II.
February 1988, Biochemical and biophysical research communications,
Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis.
March 2010, Cancer letters,
Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
Dimerization of the insulin-like growth factor II/mannose 6-phosphate receptor.
June 2000, The Journal of biological chemistry,
Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
Demonstration of tumor suppression by mannose 6-phosphate/insulin-like growth factor 2 receptor.
December 2004, Oncogene,
Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
Dissecting mannose 6-phosphate-insulin-like growth factor 2 receptor complexes that control activation and uptake of plasminogen in cells.
June 2012, The Journal of biological chemistry,
Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
Insulin-like growth factor-II/cation-independent mannose 6-phosphate receptor mediates paracrine interactions during spermatogonial development.
October 2000, Biology of reproduction,
Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
Keys to the hidden treasures of the mannose 6-phosphate/insulin-like growth factor 2 receptor.
January 2003, The American journal of pathology,
Anna Ohradanova-Repic, and Christian Machacek, and Clemens Donner, and Vanessa Mühlgrabner, and Eva Petrovčíková, and Alexandra Zahradníková, and Kristína Vičíková, and Václav Hořejší, and Hannes Stockinger, and Vladimir Leksa
The cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II.
February 1988, The Journal of biological chemistry,
Copied contents to your clipboard!